Allergan Inc. (NYSE:AGN) touted a strong quarter on the back on growing sales.
The Irvine, Calif.-based company saw strong growth in revenue in the three months ended June 30, posting $1.4 billion in sales, which amounts to a 14 percent increase over $1.2 billion in sales reporting during the same time last year.
Device sales jumped 12 percent to $245 million for the quarter, compared to $219 million in Q2 2010.
Allergan’s obesity intervention sales dropped 12 percent to $245 million, despite an expanded FDA threshold for gastric banding surgery that allows hospitals to offer the weight-loss device to patients with BMIs as low as 30 to 35.
Profits came in at $248 million, or 79 cents per diluted share, a 3 percent boost from last year’s $242 million, or 78 cents per diluted share.
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Sirona blows it out of the water
Sirona (NDSQ:SIRO) saw a boom in the three months ended June 30. The Long Island City, N.Y.-based dental company posted a stellar 34 percent increase in sales to $245 million, compared to $182 million during the same period last year.
Company profits skyrocketed 119 percent to $36.3 million, or 63 cents per diluted share, compared to $16.6 million, or 29 cents per diluted share in Q2 of 2010.
Read more
Vascular Solutions kills it in Q2
Vascular Solutions Inc. (NSDQ:VASC) saw a huge boost in the three months ended June 30. The Minneapolis, Minn.-based vascular device company posted a 14 percent increase in sales to $22.3 million, compared to $19.5 million during the same period last year.
Company profits soared 47 percent to $2.2 million, or 13 cents per diluted share, compared to $1.5 million, or 9 cents per diluted share in Q2 of 2010.
Read more
STAAR’s sales and losses improve for the quarter
STAAR Surgical Company (NASDAQ: STAA) saw growing sales and shrinking losses in the three months ended July 1. The Monrovia, Calif.-based ophthalmic company posted a 20 percent increase in sales to $16.3 million, compared to $13.6 million during the same period last year.
Company losses shrank 46 percent to a loss of $860,000, or 2 cents lost per diluted share, compared to $1.6 million, or 5 cents lost per diluted share in Q2 of 2010.
Read more
ArthroCare posts a strong quarter
ArthroCare Corp. (NSDQ:ATRC) saw healthy sales growth in the three months ended June 30. The Austin, Texas-based spinal company posted a 5 percent increase in sales to $86.9 million, compared to $83.1 million during the same period last year.
Company profits leapt 52 percent to $12.3 million, or 34 cents per diluted share, compared to $8.1 million, or 22 cents per diluted share in Q2 of 2010.
Read more
Hansen Medical sales sink and losses narrow in Q2
Hansen Medical Inc. (NSDQ:HNSN) saw sinking sales and profits in the three months ended June 30. The Mountain View, Calif.-based robotics company posted a 24 percent decrease in sales to $5.3 million, compared to $7 million during the same period last year.
Company losses shrank 20 percent to $8.8 million, or a loss of 16 cents per diluted share, compared to $11 million, or 22 cents lost per diluted share in Q2 of 2010.
Read more
Cardiovascular Systems posts strong growth
Cardiovascular Systems Inc.’s (NSDQ:CSII) saw strong growth in the three months ended June 30. The St. Paul, Minn.-based vascular disease treatment company posted a 21 percent increase in sales to $21.7 million, compared to $18 million during the same period last year.
Company losses narrowed 43 percent to $2.5 million, or a loss of 15 cents per diluted share, compared to $4.4 million, or 29 cents lost per diluted share in Q2 of 2010.
Read more
Symmetry posts sales growth, profit loss
Symmetry Medical (NYSE:SMA) saw higher operating costs in the three months ended July 2. The Warsaw, Ind.-based device company posted a 7 percent increase in sales to $94.7 million, compared to $88.8 million during the same period last year.
Company profits decreased 7 percent to $4.2 million, or 12 cents per diluted share, compared to $4.5 million, or 13 cents per diluted share in Q2 of 2010.
Read more
Viking Systems pushes forward
Viking Systems Inc. (OTC:VKNG) saw strong sales growth in the three months ended June 30. The Westborough, Mass.-based imaging company posted a 25 percent increase in sales to $2.5 million, compared to $2 million during the same period last year.
Company losses widened 90 percent to $860,000, or a loss of 1 cent per diluted share, compared to $450,000 lost in Q2 last year, also a loss of 1 cent per diluted share.
Read more
Sonosite reports strong sales and narrowed losses
SonoSite Inc. (NSDQ:SONO) saw health growth in the three months ended June 30. The Bothell, Wash.-based ultrasound company posted a 18 percent increase in sales to $72.7 million, compared to $61.5 million during the same period last year.
Company losses narrowed 37 percent to $1.2 million, or a loss of 8 cents per diluted share, compared to $1.9 million, or a loss of 12 cents per diluted share in Q2 of 2010.
Read more
BioMimetic grows sales, grows losses in second quarter
BioMimetic Therapeutics (NSDQ:BMTI) saw booming sales in the three months ended June 30. The Franklin, Tenn.-based musculoskeletal company posted a 17 percent increase in sales to $440,000, compared to $370,000 during the same period last year.
Company losses rose 6 percent to $8.2 million, or a loss of 29 cents per diluted share, compared to a loss of $7.7 million, or 35 cents lost per diluted share in Q2 of 2010.
Read more
Davita grows sales, weakens profits
DaVita Inc. (NYSE:DVA) saw profit loss in the three months ended June 30. The Denver-based device company posted a 8 percent increase in sales to $1.7 billion, compared to $1.6 billion during the same period last year.
Company profits shrank 7 percent to $100 million, or $1.03 per diluted share, compared to $108 million, or $1.04 per diluted share in Q2 of 2010.
Read more
